These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 32460581)
21. Epigenetic Regulation of S100A9 and S100A12 Expression in Monocyte-Macrophage System in Hyperglycemic Conditions. Mossel DM; Moganti K; Riabov V; Weiss C; Kopf S; Cordero J; Dobreva G; Rots MG; Klüter H; Harmsen MC; Kzhyshkowska J Front Immunol; 2020; 11():1071. PubMed ID: 32582175 [TBL] [Abstract][Full Text] [Related]
22. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. Suga T; Iso T; Shimizu T; Tanaka T; Yamagishi S; Takeuchi M; Imaizumi T; Kurabayashi M J Atheroscler Thromb; 2011; 18(8):670-83. PubMed ID: 21512281 [TBL] [Abstract][Full Text] [Related]
23. RAGE: A potential therapeutic target during FGF1 treatment of diabetes-mediated liver injury. Zheng P; Tang Z; Xiong J; Wang B; Xu J; Chen L; Cai S; Wu C; Ye L; Xu K; Chen Z; Wu Y; Xiao J J Cell Mol Med; 2021 May; 25(10):4776-4785. PubMed ID: 33788387 [TBL] [Abstract][Full Text] [Related]
24. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830 [TBL] [Abstract][Full Text] [Related]
25. RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism. Senatus L; López-Díez R; Egaña-Gorroño L; Liu J; Hu J; Daffu G; Li Q; Rahman K; Vengrenyuk Y; Barrett TJ; Dewan MZ; Guo L; Fuller D; Finn AV; Virmani R; Li H; Friedman RA; Fisher EA; Ramasamy R; Schmidt AM JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641587 [TBL] [Abstract][Full Text] [Related]
26. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo. Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559 [TBL] [Abstract][Full Text] [Related]
27. RAGE deficiency alleviates aortic valve calcification in ApoE Wang B; Cai Z; Liu B; Liu Z; Zhou X; Dong N; Li F Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):781-792. PubMed ID: 28024939 [TBL] [Abstract][Full Text] [Related]
28. The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice. Lu Y; Qin W; Shen T; Dou L; Man Y; Wang S; Xiao C; Li J J Atheroscler Thromb; 2011; 18(11):998-1008. PubMed ID: 21873804 [TBL] [Abstract][Full Text] [Related]
29. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions. Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849 [TBL] [Abstract][Full Text] [Related]
30. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Wendt T; Harja E; Bucciarelli L; Qu W; Lu Y; Rong LL; Jenkins DG; Stein G; Schmidt AM; Yan SF Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470 [TBL] [Abstract][Full Text] [Related]
31. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways. Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296 [TBL] [Abstract][Full Text] [Related]
33. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Kislinger T; Tanji N; Wendt T; Qu W; Lu Y; Ferran LJ; Taguchi A; Olson K; Bucciarelli L; Goova M; Hofmann MA; Cataldegirmen G; D'Agati V; Pischetsrieder M; Stern DM; Schmidt AM Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):905-10. PubMed ID: 11397695 [TBL] [Abstract][Full Text] [Related]
34. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis. Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436 [TBL] [Abstract][Full Text] [Related]
35. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells. Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301 [TBL] [Abstract][Full Text] [Related]
36. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis. Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587 [TBL] [Abstract][Full Text] [Related]
37. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways. Fei J; Ling YM; Zeng MJ; Zhang KW Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949 [TBL] [Abstract][Full Text] [Related]
39. López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238 [TBL] [Abstract][Full Text] [Related]